HomeAMRX • NASDAQ
add
Amneal Pharmaceuticals Inc
Previous close
$6.98
Day range
$7.03 - $7.25
Year range
$5.18 - $9.47
Market cap
2.26B USD
Avg Volume
2.05M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
MarketWatch
14 hours ago
S&P 500 tallies its first ‘death cross’ in 3 years. Here’s what happens next.
0.79%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 730.52M | 18.40% |
Operating expense | 182.95M | 17.97% |
Net income | -31.08M | 68.49% |
Net profit margin | -4.25 | 73.42% |
Earnings per share | 0.12 | -14.29% |
EBITDA | 145.12M | 13.98% |
Effective tax rate | -35.40% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 112.42M | 19.92% |
Total assets | 3.50B | 0.83% |
Total liabilities | 3.55B | 3.95% |
Total equity | -44.54M | — |
Shares outstanding | 309.97M | — |
Price to book | -19.94 | — |
Return on assets | 5.67% | — |
Return on capital | 7.65% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -31.08M | 68.49% |
Cash from operations | 118.08M | -13.06% |
Cash from investing | -16.06M | 49.33% |
Cash from financing | -61.20M | 39.30% |
Net change in cash | 40.08M | 1,045.00% |
Free cash flow | 123.52M | 19.41% |
About
Amneal Pharmaceuticals, Inc. is an American publicly traded generics and specialty pharmaceutical company. The company is headquartered in Bridgewater, New Jersey. Wikipedia
Founded
2002
Headquarters
Website
Employees
8,300
